CLOBETASOL PROPIONATE (EMOLLIENT) Drug Patent Profile
When do Clobetasol Propionate (emollient) patents expire, and when can generic versions of Clobetasol Propionate (emollient) launch?
Clobetasol Propionate (emollient) is a drug marketed by Ani Pharms, Beach Prods, Fougera Pharms, and Sun Pharma Canada. and is included in four NDAs.
The generic ingredient in CLOBETASOL PROPIONATE (EMOLLIENT) is clobetasol propionate. There is one drug master file entry for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clobetasol Propionate (emollient)
A generic version of CLOBETASOL PROPIONATE (EMOLLIENT) was approved as clobetasol propionate by COSETTE PHARMS NC on February 16th, 1994.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CLOBETASOL PROPIONATE (EMOLLIENT)?
- What are the global sales for CLOBETASOL PROPIONATE (EMOLLIENT)?
- What is Average Wholesale Price for CLOBETASOL PROPIONATE (EMOLLIENT)?
Summary for CLOBETASOL PROPIONATE (EMOLLIENT)
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Patent Applications: | 5,492 |
| DailyMed Link: | CLOBETASOL PROPIONATE (EMOLLIENT) at DailyMed |
Pharmacology for CLOBETASOL PROPIONATE (EMOLLIENT)
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
-patent-expirations.png)
